Literature DB >> 31322818

Poor survival of dialysis patients with unhealed wounds because of critical limb ischemia: Limb salvage and survival requires wound healing.

Hisao Yoshikawa1, Shingo Kujime1, Masaki Iwasaki1, Masao Yoshikawa1.   

Abstract

Maintenance of blood flow in the wound area is required to heal wounds of critical limb ischemia (CLI) in dialysis patients. However, many dialysis patients have both a stenotic lesion in below-knee blood vessels and a cardiovascular event as complications, and thus, it may be difficult to ensure sufficient blood flow. Therefore, many deaths occur because of problems with wound healing. The aim of this study is to identify the optimal treatment, including revascularisation and amputation, from the perspective of wound healing by analysing the survival of hemodialysis patients with CLI who had healed or unhealed wounds in a lower extremity. The subjects were 52 patients who received maintenance dialysis at our clinic, including 27 with healed CLI wounds and 25 with unhealed CLI wounds. The Kaplan-Meier method was used to compare survival between the two groups. Multivariate analysis was conducted to examine the effect of an unhealed wound on mortality. The mean follow-up period was 1.7 ± 1.1 years. In the unhealed wound group, the 1-, 2-, and 3-year survival rates were 48%, 20%, and 12%, respectively. The overall survival rate was significantly lower in the unhealed wound group compared with the healed wound group (12% vs 63%, P = .0002 by log-rank test). In multivariate analysis, unhealed CLI wounds had a significant independent association with mortality (hazard ratio 3.32; 95% confidence interval [CI]: 1.41-8.77, P = .0054). In this study, the 3-year survival rate suggested a significantly poorer prognosis of hemodialysis patients with unhealed CLI wounds compared with those with healed wounds. An unhealed wound is an independent risk factor for mortality in hemodialysis patients with CLI.
© 2019 Medicalhelplines.com Inc and John Wiley & Sons Ltd.

Entities:  

Keywords:  critical limb ischemia; hemodialysis patients; unhealed wound; wound healing

Mesh:

Year:  2019        PMID: 31322818      PMCID: PMC7949399          DOI: 10.1111/iwj.13162

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  17 in total

1.  Prediction of Development of Critical Limb Ischemia in Hemodialysis Patients.

Authors:  Hisao Yoshikawa; Raisuke Iijima; Go Hashimoto; Hidehiko Hara; Kiyotsugu Omae; Yumiko Yoshikawa; Makoto Suzuki; Masato Nakamura; Kaoru Sugi; Masao Yoshikawa
Journal:  Ther Apher Dial       Date:  2015-03-25       Impact factor: 1.762

2.  Prognostic Factors in Hemodialysis Patients Undergoing Endovascular Treatment for Critical Limb Ischemia due to Isolated Below-the-Knee Disease.

Authors:  Nobuhiro Suematsu; Osamu Iida; Mitsuyoshi Takahara; Yasutaka Yamauchi; Yoshimitsu Soga; Masatsugu Nakano; Keisuke Hirano; Daizo Kawasaki; Terutoshi Yamaoka; Kenji Suzuki; Yoshiaki Shintani; Yusuke Miyashita; Junichi Tazaki; Hiroshi Meno; Tetsuji Inou
Journal:  J Atheroscler Thromb       Date:  2014-10-25       Impact factor: 4.928

3.  Predictors of delayed wound healing after endovascular therapy of isolated infrapopliteal lesions underlying critical limb ischemia in patients with high prevalence of diabetes mellitus and hemodialysis.

Authors:  T Shiraki; O Iida; M Takahara; Y Soga; Y Yamauchi; K Hirano; D Kawasaki; M Fujihara; M Utsunomiya; J Tazaki; T Yamaoka; Y Shintani; N Suematsu; K Suzuki; Y Miyashita; T Tsuchiya; M Uematsu
Journal:  Eur J Vasc Endovasc Surg       Date:  2015-03-04       Impact factor: 7.069

4.  Angiographic restenosis and its clinical impact after infrapopliteal angioplasty.

Authors:  O Iida; Y Soga; D Kawasaki; K Hirano; T Yamaoka; K Suzuki; Y Miyashita; H Yokoi; M Takahara; M Uematsu
Journal:  Eur J Vasc Endovasc Surg       Date:  2012-08-28       Impact factor: 7.069

5.  Sarcopenia is a prognostic factor for overall survival in patients with critical limb ischemia.

Authors:  Yutaka Matsubara; Takuya Matsumoto; Yukihiko Aoyagi; Shinichi Tanaka; Jun Okadome; Koichi Morisaki; Ken Shirabe; Yoshihiko Maehara
Journal:  J Vasc Surg       Date:  2014-12-10       Impact factor: 4.268

6.  Major lower extremity amputation: outcome of a modern series.

Authors:  Bernadette Aulivola; Chantel N Hile; Allen D Hamdan; Malachi G Sheahan; Jennifer R Veraldi; John J Skillman; David R Campbell; Sherry D Scovell; Frank W LoGerfo; Frank B Pomposelli
Journal:  Arch Surg       Date:  2004-04

7.  Healing of ischaemic tissue lesions after infrainguinal bypass surgery for critical leg ischaemia.

Authors:  M Söderström; E Arvela; A Albäck; P-S Aho; M Lepäntalo
Journal:  Eur J Vasc Endovasc Surg       Date:  2008-03-20       Impact factor: 7.069

8.  An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013).

Authors:  Ikuto Masakane; Shigeru Nakai; Satoshi Ogata; Naoki Kimata; Norio Hanafusa; Takayuki Hamano; Kenji Wakai; Atsushi Wada; Kosaku Nitta
Journal:  Ther Apher Dial       Date:  2015-12       Impact factor: 1.762

9.  Association of diabetes and hemodialysis with ankle pressure and ankle-brachial index in Japanese patients with critical limb ischemia.

Authors:  Mitsuyoshi Takahara; Hideaki Kaneto; Osamu Iida; Naoto Katakami; Taka-Aki Matsuoka; Masahiko Ikeda; Iichiro Shimomura
Journal:  Diabetes Care       Date:  2012-06-20       Impact factor: 19.112

10.  Mortality after major amputation in elderly patients with critical limb ischemia.

Authors:  Sanne Klaphake; Kevin de Leur; Paul Gh Mulder; Gwan H Ho; Hans G de Groot; Eelco J Veen; Hence Jm Verhagen; Lijckle van der Laan
Journal:  Clin Interv Aging       Date:  2017-11-22       Impact factor: 4.458

View more
  2 in total

1.  Poor survival of dialysis patients with unhealed wounds because of critical limb ischemia: Limb salvage and survival requires wound healing.

Authors:  Hisao Yoshikawa; Shingo Kujime; Masaki Iwasaki; Masao Yoshikawa
Journal:  Int Wound J       Date:  2019-07-19       Impact factor: 3.315

2.  Phase I/IIa Feasibility Trial of Autologous Quality- and Quantity-Cultured Peripheral Blood Mononuclear Cell Therapy for Non-Healing Extremity Ulcers.

Authors:  Rica Tanaka; Satoshi Fujimura; Makiko Kado; Taro Fukuta; Kayo Arita; Rie Hirano-Ito; Tomoya Mita; Hirotaka Watada; Yoshiteru Kato; Katsumi Miyauchi; Hiroshi Mizuno
Journal:  Stem Cells Transl Med       Date:  2022-03-17       Impact factor: 6.940

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.